Vir Biotechnology, Inc. (NASDAQ:VIR – Get Free Report) CEO Backer Marianne De sold 72,995 shares of the business’s stock in a transaction that occurred on Wednesday, April 3rd. The stock was sold at an average price of $9.46, for a total value of $690,532.70. Following the sale, the chief executive officer now directly owns 678,457 […]
Related Keywords
China , , Quadrant Capital Group , Jpmorgan Chase Co , Third Bancorp , Fifth Third Bancorp , Vir Biotechnology Inc , China Universal Asset Management Co , Nasdaq , Vir Biotechnology , Get Free Report , Biotechnology Trading Down , Capital Group , Universal Asset Management , Captrust Financial Advisors , Financial Advisors , Vir Biotechnology Daily , Nasdaq Vir , Ivir , Medical , Insider Trading , Nsider Trades , Stocks ,
comparemela.com © 2020. All Rights Reserved.